These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29168473)

  • 1. Yangxin Tongmai Formula ameliorates impaired glucose tolerance in children with Graves' disease through upregulation of the insulin receptor levels.
    Luo YH; Zhu M; Wang DG; Yang YS; Tan T; Zhu H; He JF
    Acta Pharmacol Sin; 2018 Jun; 39(6):923-929. PubMed ID: 29168473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HbA1c in the diagnosis of diabetes and abnormal glucose tolerance in patients with Graves' hyperthyroidism.
    Yang L; Shen X; Yan S; Yuan X; Lu J; Wei W
    Diabetes Res Clin Pract; 2013 Jul; 101(1):28-34. PubMed ID: 23684448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Chinese Herbal Medicine Jinlida Granule in Treatment of Patients with Impaired Glucose Tolerance.
    Shi YL; Liu WJ; Zhang XF; Su WJ; Chen NN; Lu SH; Wang LY; Shi XL; Li ZB; Yang SY
    Chin Med J (Engl); 2016 Oct; 129(19):2281-6. PubMed ID: 27647185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical effect of Tangyiping Granules () on patients with impaired glucose tolerance.
    Huang YQ; Yang QF; Wang H; Xu YS; Peng W; Jiang YH
    Chin J Integr Med; 2016 Sep; 22(9):653-9. PubMed ID: 27614450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delphinol® standardized maqui berry extract reduces postprandial blood glucose increase in individuals with impaired glucose regulation by novel mechanism of sodium glucose cotransporter inhibition.
    Hidalgo J; Flores C; Hidalgo MA; Perez M; Yañez A; Quiñones L; Caceres DD; Burgos RA
    Panminerva Med; 2014 Jun; 56(2 Suppl 3):1-7. PubMed ID: 24861886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
    Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
    J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial.
    Osei E; Fonville S; Zandbergen AA; Brouwers PJ; Mulder LJ; Lingsma HF; Dippel DW; Koudstaal PJ; den Hertog HM
    Trials; 2015 Aug; 16():332. PubMed ID: 26242578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
    Chiasson JL
    Diabet Med; 1996; 13(3 Suppl 2):S23-4. PubMed ID: 8689858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of insulin secretion and insulin resistance by hyperglycemic clamp in Graves disease patients with impaired glucose tolerance].
    Liang Z; Luo GC; Hu QH; Li MZ; Chen N; Yan DW; Chai J; Chen ZL; Li HY; Ou HT
    Zhonghua Nei Ke Za Zhi; 2007 Jul; 46(7):559-61. PubMed ID: 17959079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low-intensity ergometer aerobic training on glucose tolerance in severely impaired nondiabetic stroke patients.
    Wang Z; Wang L; Fan H; Lu X; Wang T
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e187-93. PubMed ID: 24231135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting RHOA Signaling in Mice Increases Glucose Tolerance and Numbers of Enteroendocrine and Other Secretory Cells in the Intestine.
    Petersen N; Frimurer TM; Terndrup Pedersen M; Egerod KL; Wewer Albrechtsen NJ; Holst JJ; Grapin-Botton A; Jensen KB; Schwartz TW
    Gastroenterology; 2018 Oct; 155(4):1164-1176.e2. PubMed ID: 29935151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose and insulin metabolism in patients with hyperthyroidism due to Graves' disease.
    Mano T; Kawakubo A; Yamamoto M
    Nagoya J Med Sci; 1994 Mar; 57(1-4):61-8. PubMed ID: 7898563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
    Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
    Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pediatric Case of Graves' Hyperthyroidism with Associated Glucose Intolerance Detected by a Urine Glucose Screening Program at School.
    Ikegami T; Yamamoto Y; Goto M; Kawagoe R; Kawada Y; Kusuhara K
    J UOEH; 2018; 40(3):231-236. PubMed ID: 30224619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acarbose treatment on markers of insulin sensitivity and systemic inflammation.
    Rudovich NN; Weickert MO; Pivovarova O; Bernigau W; Pfeiffer AF
    Diabetes Technol Ther; 2011 Jun; 13(6):615-23. PubMed ID: 21488802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Goiter Dispersion Formula on Serum Cytokines in Hyperthyroidism Patients with Neurologic Manifestations of Graves' Disease: A Randomized Trial on 80 Cases.
    Tian WH; Wang Y; Yang R; Hu HB
    J Altern Complement Med; 2018 May; 24(5):481-485. PubMed ID: 29406821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose.
    Goossens GH; Moors CC; Jocken JW; van der Zijl NJ; Jans A; Konings E; Diamant M; Blaak EE
    Nutrients; 2016 Mar; 8(3):164. PubMed ID: 26985905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose.
    Utzschneider KM; Tong J; Montgomery B; Udayasankar J; Gerchman F; Marcovina SM; Watson CE; Ligueros-Saylan MA; Foley JE; Holst JJ; Deacon CF; Kahn SE
    Diabetes Care; 2008 Jan; 31(1):108-13. PubMed ID: 17909087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.